|
1
|
Pan GH, Chen Z, Xu L, Zhu JH, Xiang P, Ma
JJ, Peng YW, Li GH, Chen XY, Fang JL, et al: Low-dose tacrolimus
combined with donor-derived mesenchymal stem cells after renal
transplantation: A prospective, non-randomized study. Oncotarget.
7:12089–12101. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Strohmaier S, Wallisch C, Kammer M,
Geroldinger A, Heinze G, Oberbauer R and Haller MC: Survival
benefit of first single-organ deceased donor kidney transplantation
compared with long-term dialysis across ages in transplant-eligible
patients with kidney failure. JAMA Netw Open.
5(e2234971)2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Li J, Luo Y, Wang X and Feng G: Regulatory
B cells and advances in transplantation. J Leukoc Biol.
105:657–668. 2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Sellarés J, de Freitas DG, Mengel M, Reeve
J, Einecke G, Sis B, Hidalgo LG, Famulski K, Matas A and Halloran
PF: Understanding the causes of kidney transplant failure: The
dominant role of antibody-mediated rejection and nonadherence. Am J
Transplant. 12:388–399. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lim WH, Wong G, Heidt S and Claas FHJ:
Novel aspects of epitope matching and practical application in
kidney transplantation. Kidney Int. 93:314–324. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gunawansa N, Rathore R, Sharma A and
Halawa A: Crossmatch strategies in renal transplantation: A
practical guide for the practicing clinician. J Transplant Surg.
1:8–15. 2017.
|
|
7
|
Tellis VA, Matas AJ, Senitzer D, Louis P,
Glicklich D, Soberman R and Veith FJ: Successful transplantation
after conversion of a positive crossmatch to negative by
dissociation of IgM antibody. Transplantation. 47:127–129.
1989.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Opelz G and Döhler B: Effect of human
leukocyte antigen compatibility on kidney graft survival:
Comparative analysis of two decades. Transplantation. 84:137–143.
2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Cecka JM: HLA matching for renal
transplantation: The last word? Transplantation. 100:975–976.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lim WH, Chapman JR, Coates PT, Lewis JR,
Russ GR, Watson N, Holdsworth R and Wong G: HLA-DQ mismatches and
rejection in kidney transplant recipients. Clin J Am Soc Nephrol.
11:875–883. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Leeaphorn N, Pena JRA, Thamcharoen N,
Khankin EV, Pavlakis M and Cardarelli F: HLA-DQ mismatching and
kidney transplant outcomes. Clin J Am Soc Nephrol. 13:763–771.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Süsal C, Döhler B and Opelz G:
Presensitized kidney graft recipients with HLA class I and II
antibodies are at increased risk for graft failure: A collaborative
transplant study report. Hum Immunol. 70:569–573. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Michielsen LA, Wisse BW, Kamburova EG,
Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB,
Baas MC, Spierings E, et al: A paired kidney analysis on the impact
of pre-transplant anti-HLA antibodies on graft survival. Nephrol
Dial Transplant. 34:1056–1063. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Solgi G, Furst D, Mytilineos J, Pourmand G
and Amirzargar AA: Clinical relevance of pre and post-transplant
immune markers in kidney allograft recipients: Anti-HLA and MICA
antibodies and serum levels of sCD30 and sMICA. Transpl Immunol.
26:81–87. 2012.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zschiedrich S, Jänigen B, Dimova D,
Neumann A, Seidl M, Hils S, Geyer M, Emmerich F, Kirste G, Drognitz
O, et al: One hundred ABO-incompatible kidney transplantations
between 2004 and 2014: A single-centre experience. Nephrol Dial
Transplant. 31:663–671. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Koo TY, Lee J, Lee Y, Kim HW, Kim BS, Huh
KH and Yang J: Outcomes of ABO-incompatible living donor kidney
transplantation compared to waiting or deceased donor kidney
transplantation. Am J Nephrol. 55:235–244. 2024.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Massie AB, Orandi BJ, Waldram MM, Luo X,
Nguyen AQ, Montgomery RA, Lentine KL and Segev DL: Impact of
ABO-incompatible living donor kidney transplantation on patient
survival. Am J Kidney Dis. 76:616–623. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Chow KV, Flint SM, Shen A, Landgren A,
Finlay M, Murugasu A, Masterson R, Hughes P and Cohney SJ:
Histological and extended clinical outcomes after ABO-incompatible
renal transplantation without splenectomy or rituximab.
Transplantation. 101:1433–1440. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lyman JL: Blood urea nitrogen and
creatinine. Emerg Med Clin North Am. 4:223–233. 1986.PubMed/NCBI
|
|
20
|
Ruilope LM, Ortiz A, Lucia A, Miranda B,
Alvarez-Llamas G, Barderas MG, Volpe M, Ruiz-Hurtado G and Pitt B:
Prevention of cardiorenal damage: Importance of albuminuria. Eur
Heart J. 44:1112–1123. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Levey AS, Atkins R, Coresh J, Cohen EP,
Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, et
al: Chronic kidney disease as a global public health problem:
approaches and initiatives-a position statement from kidney disease
improving global outcomes. Kidney Int. 72:247–259. 2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Clayton PA, Lim WH, Wong G and Chadban SJ:
Relationship between eGFR decline and hard outcomes after kidney
transplants. J Am Soc Nephrol. 27:3440–3446. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Raynaud M, Aubert O, Reese PP, Bouatou Y,
Naesens M, Kamar N, Bailly É, Giral M, Ladrière M, Le Quintrec M,
et al: Trajectories of glomerular filtration rate and progression
to end stage kidney disease after kidney transplantation. Kidney
Int. 99:186–197. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang X, Lyu J, Yu X, Wang L, Peng W, Chen
J and Wu J: Comparison of graft outcome between donation after
circulatory death and living-donor kidney transplantation.
Transplant Proc. 52:111–118. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chen L, Bai H, Jin H, Zhang T, Shi B, Cai
M and Wang Y: Outcomes in kidney transplantation with mycophenolate
mofetil-based maintenance immunosuppression in China: A
large-sample retrospective analysis of a national database. Transpl
Int. 33:718–728. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Cantarelli C, Angeletti A and Cravedi P:
Erythropoietin, a multifaceted protein with innate and adaptive
immune modulatory activity. Am J Transplant. 19:2407–2414.
2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bachman E, Travison TG, Basaria S, Davda
MN, Guo W, Li M, Connor Westfall J, Bae H, Gordeuk V and Bhasin S:
Testosterone induces erythrocytosis via increased erythropoietin
and suppressed hepcidin: evidence for a new
erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci.
69:725–735. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Winkelmayer WC, Lorenz M, Kramar R, Hörl
WH and Sunder-Plassmann G: Percentage of hypochromic red blood
cells is an independent risk factor for mortality in kidney
transplant recipients. Am J Transplant. 4:2075–2081.
2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ogawa C, Tsuchiya K and Maeda K:
Reticulocyte hemoglobin content. Clin Chim Acta. 504:138–145.
2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Tornero F, Prats D, Alvarez-Sala JL,
Coronel F, Sanchez A and Barrientos A: Iron deficiency anemia after
successful renal transplantation. J Urol. 149:1398–1400.
1993.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bonnefoy-Berard N, Verrier B, Vincent C
and Revillard JP: Inhibition of CD25 (IL-2R alpha) expression and
T-cell proliferation by polyclonal anti-thymocyte globulins.
Immunology. 77:61–67. 1992.PubMed/NCBI
|
|
32
|
Alamartine E, Bellakoul R and Berthoux F:
Randomized prospective study comparing OKT3 and antithymocyte
globulins for treatment of the first acute cellular rejection of
kidney allografts. Transplant Proc. 26:273–274. 1994.PubMed/NCBI
|
|
33
|
Soulillou JP, Cantarovich D, Le Mauff B,
Giral M, Robillard N, Hourmant M, Hirn M and Jacques Y: Randomized
controlled trial of a monoclonal antibody against the interleukin-2
receptor (33B3.1) as compared with rabbit antithymocyte globulin
for prophylaxis against rejection of renal allografts. N Engl J
Med. 322:1175–1182. 1990.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kawahara T, Fukui S, Sakamaki K, Ito Y,
Ito H, Kobayashi N, Izumi K, Yokomizo Y, Miyoshi Y, Makiyama K, et
al: Neutrophil-to-lymphocyte ratio predicts prostatic carcinoma in
men undergoing needle biopsy. Oncotarget. 6:32169–32176.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Kawahara T, Furuya K, Nakamura M, Sakamaki
K, Osaka K, Ito H, Ito Y, Izumi K, Ohtake S, Miyoshi Y, et al:
Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder
cancer patients after radical cystectomy. BMC Cancer.
16(185)2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Dujardin A, Lorent M, Foucher Y, Legendre
C, Kerleau C, Brouard S and Giral M: DIVAT Consortium.
Time-dependent lymphocyte count after transplantation is associated
with higher risk of graft failure and death. Kidney Int.
99:1189–1201. 2021.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bloom RD and Augustine JJ: Beyond the
biopsy: Monitoring immune status in kidney recipients. Clin J Am
Soc Nephrol. 16:1413–1422. 2021.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Long W, Zhang H, Yuan W, Lan G, Lin Z,
Peng L and Dai H: The role of regulatory B cells in kidney
diseases. Front Immunol. 12(683926)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Huang DL, He YR, Liu YJ, He HY, Gu ZY, Liu
YM, Liu WJ, Luo Z and Ju MJ: The immunomodulation role of Th17 and
Treg in renal transplantation. Front Immunol.
14(1113560)2023.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Nashan B, Abbud-Filho M and Citterio F:
Prediction, prevention, and management of delayed graft function:
where are we now? Clin Transplant. 30:1198–1208. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Redfield RR, Scalea JR, Zens TJ, Muth B,
Kaufman DB, Djamali A, Astor BC and Mohamed M: Predictors and
outcomes of delayed graft function after living-donor kidney
transplantation. Transpl Int. 29:81–87. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Ojo AO, Wolfe RA, Held PJ, Port FK and
Schmouder RL: Delayed graft function: Risk factors and implications
for renal allograft survival. Transplantation. 63:968–974.
1997.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Sellers MT, Gallichio MH, Hudson SL, Young
CJ, Bynon JS, Eckhoff DE, Deierhoi MH, Diethelm AG and Thompson JA:
Improved outcomes in cadaveric renal allografts with pulsatile
preservation. Clin Transplant. 14:543–549. 2000.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Molnar MZ, Kovesdy CP, Rosivall L,
Bunnapradist S, Hoshino J, Streja E, Krishnan M and Kalantar-Zadeh
K: Associations of pre-transplant anemia management with
post-transplant delayed graft function in kidney transplant
recipients. Clin Transplant. 26:782–791. 2012.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Morath C, Döhler B, Kälble F, Pego da
Silva L, Echterdiek F, Schwenger V, Živčić-Ćosić S, Katalinić N,
Kuypers D, Benöhr P, et al: Pre-transplant HLA antibodies and
delayed graft function in the current era of kidney
transplantation. Front Immunol. 11(1886)2020.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Peräsaari JP, Kyllönen LE, Salmela KT and
Merenmies JM: Pre-transplant donor-specific anti-human leukocyte
antigen antibodies are associated with high risk of delayed graft
function after renal transplantation. Nephrol Dial Transplant.
31:672–678. 2016.PubMed/NCBI View Article : Google Scholar
|
